Global Personalized Cell Therapy Market Is Estimated To Witness High Growth Owing To Increasing Prevalence of Chronic Diseases

1
Personalized Cell Therapy Market Revolutionary
Approach To The Healthcare System
Personalized Cell Therapy Market The
Personalized Cell Therapy Market is estimated
to be valued at USD 12,572.34 million in 2022
and is expected to exhibit a CAGR of 24 over the
forecast period of 2022-2030, according to a
new report published by Coherent Market
Insights. Personalized cell therapy refers to the
use of a patient's own cells for the treatment of
various diseases. This therapy holds great
potential in the field of regenerative
medicine and has shown promising results in
the treatment of cancer, cardiovascular
diseases, neurological disorders, and other
chronic conditions. The market is driven by
factors such as increasing prevalence of chronic
diseases, advancements in cell-based therapies,
and growing demand for personalized
medicine. Market Dynamics The Personalized
Cell Therapy Market is primarily driven by two
main factors 1. Increasing prevalence of
chronic diseases The rise in chronic diseases
such as cancer, cardiovascular diseases, and
autoimmune disorders has created a significant
need for personalized treatments.
Personalized cell therapy offers a targeted
approach to treatment by using a patient's own
cells, thereby reducing the risk of rejection and
improving patient outcomes.
2

• For example, CAR-T cell therapy has shown
  remarkable success in treating certain types
  of blood cancers, providing long-term
  remission and improving survival rates.
• 2. Advancements in cell-based therapies
  Technological advancements in cell-based
  therapies have revolutionized the field of
  regenerative medicine. New techniques such as
  gene editing, stem cell therapy, and
  tissue engineering have opened up new avenues for
  personalized cell therapy. For instance,
  CRISPR-Cas9 technology allows precise genetic
  modifications to be made in cells, enabling
  the development of personalized therapies
  for genetic disorders.
• Market Key Trends
• One key trend in the Personalized Cell Therapy
  Market is the increasing adoption of
  immunotherapy. Immunotherapy involves
  stimulating the body's immune system to fight
  against cancer cells or other diseases. It has
  gained significant attention in recent years due
  to its high success rates and minimal side
  effects compared to traditional
  treatments such as chemotherapy and
  radiation therapy. For example, immune
  checkpoint inhibitors such as pembrolizumab and
  nivolumab have shown promising results in the
  treatment of various cancers by blocking proteins
  that inhibit the immune response.
• SWOT Analysis Strengths
• Growing demand for personalized medicine
• Advancements in cell-based therapies
• Weaknesses
• High costs associated with personalized cell
  therapy
• Limited infrastructure for cell therapy
  manufacturing
• Opportunities
• Increasing investments in regenerative medicine
  research
• Development of novel cell therapies for rare
  diseases

Threats
3

• Stringent regulatory guidelines for cell therapy
• Ethical issues related to gene editing and
  genetic modifications
• Key Takeaways
• The global Personalized Cell Therapy Market is
  expected to witness high growth, exhibiting a
  CAGR of 24 over the forecast period. This growth
  is driven by the increasing prevalence of chronic
  diseases and advancements in cell-based
  therapies. The market is dominated by North
  America, followed by Europe and Asia-Pacific, due
  to the presence of established healthcare
  infrastructure, high adoption rate of
  innovative therapies, and strong government
  support. Key players operating in the market
  include Cytori Therapeutics Inc., Bellicum
  Pharmaceuticals, Inc., Saneron CCEL
  Therapeutics, Inc., MolMed S.p.A., Vericel
  Corporation, Novartis AG, Gilead Sciences,
  Inc., Celgene Corporation, Bluebird Bio,
  Inc., and Aurora Biopharma Inc. These
  companies are focused on research and development
  activities to introduce innovative personalized
  cell therapies and expand their market presence.